The charts on this page feature a breakdown of the total annual pay for the top executives at Teladoc Health, Inc. as reported in their proxy statements.

Total Cash Compensation information is comprised of yearly Base Pay and Bonuses. Teladoc Health, Inc. income statements for executive base pay and bonus are filed yearly with the SEC in the edgar filing system. Teladoc Health, Inc. annual reports of executive compensation and pay are most commonly found in the Def 14a documents.

Total Equity aggregates grant date fair value of stock and option awards and long term incentives granted during the fiscal year.

Other Compensation covers all compensation-like awards that don't fit in any of these other standard categories. Numbers reported do not include change in pension value and non-qualified deferred compensation earnings.

Name And Title Total Cash Equity Other Total Compensation
Jason Gorevic
Chief Executive Officer
Total Cash $1,184,500 Equity $6,799,988 Other $11,200 Total Compensation $7,995,688
Adam Vandervoort
Chief Legal Officer
Total Cash $529,796 Equity $1,400,041 Other $11,200 Total Compensation $1,941,037
Peter McClennen
Former President
Total Cash $1,037,300 Equity $3,000,031 Other $11,200 Total Compensation $4,048,531
Stephany Verstraete
Chief Marketing Officer
Total Cash $502,616 Equity $1,500,015 Other $750 Total Compensation $2,003,381
Mala Murthy
Chief Financial Officer
Total Cash $437,056 Equity $2,997,995 Other $5,313 Total Compensation $3,440,364
Gabe Cappucci
Senior Vice President, Chief Accounting Officer and Controller
Total Cash $414,298 Equity $299,990 Other $11,200 Total Compensation $725,488
David Sides
Chief Operating Officer
Total Cash $519,447 Equity $2,998,552 Other $144,283 Total Compensation $3,662,282
For its 2019 fiscal year, Teladoc Health, Inc., listed the following CEO pay ratio data on its annual proxy statement to the SEC.
CEO Name CEO Pay Median Employee Pay CEO Pay Ratio
Jason Gorevic CEO Pay $7,995,688 Median Employee Pay $53,436 CEO Pay Ratio 150:1
For its 2019 fiscal year, Teladoc Health, Inc., listed the following board members on its annual proxy statement to the SEC.
Name Total COMPENSATION
Arneek Multani Total Cash $232,500
Brian McAndrews Total Cash $232,500
David B. Snow, Jr. Total Cash $265,833
David Shedlarz Total Cash $242,500
Helen Darling Total Cash $220,000
Kenneth Paulus Total Cash $224,583
Mark Douglas Smith, M.D. Total Cash $219,167
Michael Goldstein Total Cash $239,167
Thomas G. McKinley Total Cash $230,000
William H. Frist, M.D. Total Cash $229,583

This report is not for commercial use. Thorough reviews have been conducted to assure this data accurately reflects disclosures. However for a complete and definitive understanding of the pay practices of any company, users should refer directly to the actual, complete proxy statement.

The information shown here is a reporting of information included in the company's proxy statement. The proxy statement includes footnotes and explanations of this information plus other information that is pertinent in assessing the overall value and appropriateness of the compensation information. For those interested in conducting a detailed compensation analysis, we recommend that you review the entire proxy statement. You may retrieve the full proxy statement by going to the Securities and Exchange Commission (SEC) website at www.sec.gov and entering the company's name and then looking in the first column for an entry of "Form DEF 14A" (or any similar code). You may also find the annual proxy statement by going directly to the company's website.

A proxy statement (or "proxy") is a form that every publicly traded U.S. company is required to file with the U.S. Securities & Exchange Commission (SEC) within 120 days after the end of its fiscal year. The proxy must be sent to every shareholder in advance of the company's annual shareholders meeting. All proxy statements are public filings made available to the general public by the SEC.

The proxy statement's main purpose is to alert shareholders to the annual meeting and provide them information about the issues that will be voted on during the annual meeting, including decisions such as electing directors, ratifying the selection of auditors, and other shareholder-related decisions, including shareholder-initiated initiatives. Also, proxies must disclose specific detailed information regarding the pay practices for certain executives.